KUMAR NEIL (See Remarks) sold 1.8% of their position (80K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $5.39M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−11.22K
Price / share
$67.50
Trade value
$757.09K
% of position
Common Stock
Shares
−8.33K
Price / share
$68.38
Trade value
$569.79K
% of position
Common Stock
Shares
−450.00
Price / share
$69.09
Trade value
$31.09K
% of position
Common Stock
Shares
−11.22K
Price / share
$67.49
Trade value
$757.09K
% of position
Common Stock
Shares
−8.33K
Price / share
$68.38
Trade value
$569.86K
% of position
Common Stock
Shares
−449.00
Price / share
$69.09
Trade value
$31.02K
% of position
Common Stock
Shares
−13.97K
Price / share
$66.65
Trade value
$931.31K
% of position
Common Stock
Shares
−5.08K
Price / share
$67.35
Trade value
$341.91K
% of position
Common Stock
Shares
−950.00
Price / share
$68.35
Trade value
$64.93K
% of position
Common Stock
Shares
−13.97K
Price / share
$66.65
Trade value
$931.37K
% of position
Common Stock
Shares
−5.08K
Price / share
$67.35
Trade value
$341.85K
% of position
Common Stock
Shares
−950.00
Price / share
$68.35
Trade value
$64.93K
% of position
Net shares
−80K
Net value
-$5.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/7/2026 | S · Sale | −11.22K | $67.50 | $757.09K | 1.9% | 595.69K | 584.47K |
| Common Stock Indirect | 5/7/2026 | S · Sale | −8.33K | $68.38 | $569.79K | 1.4% | 584.47K | 576.14K |
| Common Stock Indirect | 5/7/2026 | S · Sale | −450.00 | $69.09 | $31.09K | 0.1% | 576.14K | 575.69K |
| Common Stock Indirect | 5/7/2026 | S · Sale | −11.22K | $67.49 | $757.09K | 0.3% | 4.40M | 4.39M |
| Common Stock Indirect | 5/7/2026 | S · Sale | −8.33K | $68.38 | $569.86K | 0.2% | 4.39M | 4.38M |
| Common Stock Indirect | 5/7/2026 | S · Sale | −449.00 | $69.09 | $31.02K | 0.0% | 4.38M | 4.38M |
| Common Stock Indirect | 5/8/2026 | S · Sale | −13.97K | $66.65 | $931.31K | 2.4% | 575.69K | 561.71K |
| Common Stock Indirect | 5/8/2026 | S · Sale | −5.08K | $67.35 | $341.91K | 0.9% | 561.71K | 556.64K |
| Common Stock Indirect | 5/8/2026 | S · Sale | −950.00 | $68.35 | $64.93K | 0.2% | 556.64K | 555.69K |
| Common Stock Indirect | 5/8/2026 | S · Sale | −13.97K | $66.65 | $931.37K | 0.3% | 4.38M | 4.36M |
| Common Stock Indirect | 5/8/2026 | S · Sale | −5.08K | $67.35 | $341.85K | 0.1% | 4.36M | 4.36M |
| Common Stock Indirect | 5/8/2026 | S · Sale | −950.00 | $68.35 | $64.93K | 0.0% | 4.36M | 4.36M |
| Total | −80K | -$5.39M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 234.45K | Direct |
| Total | 234.45K | 234.45K direct |